vimarsana.com

Latest Breaking News On - Ceapro inc stock exchange - Page 1 : vimarsana.com

Ceapro Announces Results of 2023 Shareholders Meeting

EDMONTON, Alberta, June 07, 2023 Ceapro Inc. , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic. | June 7, 2023

William liJenene thomasUlrich kosciessaGlenn rourkeRonaldw millerGilles gagnonGillesr gagnonCorporate communications advisorCeapro incAnnual generalSpecial meetingStock option planCorporate communicationsCeapro inc stock exchangePress releaseNd czo ca1499071076

Ceapro Inc Reports Financial Results for First Quarter 2023 and Provides Corporate Update

– Q1 2023 sales of $3,500,000 vs $6,172,000 in Q1 2022 – Ended the quarter with $12.6 million in cash allowing funding for planned pipeline development EDMONTON, Alberta, May . | May 25, 2023

United statesBeta glucanJenene thomasGillesr gagnonGilles gagnonCorporate communications advisorPipeline developmentClinical developmentAngiogenesis foundationVenture exchangeMontreal heart instituteMcmaster universityCeapro incExpanded technologyFirst in human studyAssess safety

Ceapro Inc Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases

– Results from the completed Collaborative Health Research Projects study with McMaster University presented at the American Thoracic Society International Conference – – Data. | May 23, 2023

United statesSafaa naielJenene thomasNate dowdallMartin kolbGillesr gagnonTodd hoareGilles gagnonBernhard seifriedMcmaster universityProfessor of medicine at mcmaster universityDepartment of chemical engineering at mcmaster universityCeapro incCollaborative health research projectsXpanded liquid technologyDepartment of agricultural

Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration

– Data presented at 2023 Annual Meeting of the Wound Healing Society showed statistically significant results characterizing the in vivo bioactivity of Ceapro’s oat-derived bioactive. | May 3, 2023

William liGilles gagnonJenene thomasGillesr gagnonCorporate communications advisorAngiogenesis foundation disclosureAngiogenesis foundationMeeting of the wound healing societyUniversity of arizonaCeapro incWound healing societyNew england journalCeapro inc stock exchangePress releaseF czo ca1499071076

Ceapro : 2022 Year End Consolidated Financial Statements

OTCQX: CRPOF The MD&A provides commentary on the results of operations for the years ended December 31, 2022 and 2021, the financial position as at. | April 12, 2023

United statesPrince edward islandJuventedc incCeapro incInternational financial reporting standardsCeapro active ingredients incCeaprop ei incCeapro technology incCeapro united states incCeapro bioenergy incCore businessCanada business corporations actAlberta business corporationsPrince edwardCeapro united statesCanada business corporations

vimarsana © 2020. All Rights Reserved.